Dr. Todd Lucas, a team of Michigan State University researchers, and their partners are leading a $1.2M NIH study with a pair of formidable goals: communicating effectively about the value of COVID-19 antibody testing and better understanding why COVID-19 causes a disproportionate number of African Americans to suffer severe cases and deaths. The project is part of the NIH Serological Sciences Network for COVID-19 initiative.